Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

Atomoxetine Hydrochloride

×

Overview

What is Atomoxetine Hydrochloride?



What does Atomoxetine Hydrochloride look like?



What are the available doses of Atomoxetine Hydrochloride?

Sorry No records found.

What should I talk to my health care provider before I take Atomoxetine Hydrochloride?

Sorry No records found

How should I use Atomoxetine Hydrochloride?


What interacts with Atomoxetine Hydrochloride?

Sorry No Records found


What are the warnings of Atomoxetine Hydrochloride?

Sorry No Records found


What are the precautions of Atomoxetine Hydrochloride?

Sorry No Records found


What are the side effects of Atomoxetine Hydrochloride?

Sorry No records found


What should I look out for while using Atomoxetine Hydrochloride?


What might happen if I take too much Atomoxetine Hydrochloride?


How should I store and handle Atomoxetine Hydrochloride?

Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Protect from light.Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Protect from light.Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Protect from light.Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Protect from light.Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Estradiol Tablets, USP are available containing 0.5 mg or 1 mg of estradiol, USP.The 0.5 mg tablets are white to off-white round, scored tablets debossed with to the left of the score and to the right of the score on one side of the tablet and on the other side. They are available as follows:NDC 0179-0073-70Box of 30 Unit Dose TabletsThe 1 mg tablets are pink round, scored tablets debossed with to the left of the score and to the right of the score on one side of the tablet and on the other side. They are available as follows:NDC 0179-0074-70Box of 30 Unit Dose TabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Mylan Pharmaceuticals Inc.Morgantown, WV 26505REVISED DECEMBER 2009ESTRT:R4ppt Repackaged by: KAISER FOUNDATION HOSPITALS Livermore, CA 94551Estradiol Tablets, USP are available containing 0.5 mg or 1 mg of estradiol, USP.The 0.5 mg tablets are white to off-white round, scored tablets debossed with to the left of the score and to the right of the score on one side of the tablet and on the other side. They are available as follows:NDC 0179-0073-70Box of 30 Unit Dose TabletsThe 1 mg tablets are pink round, scored tablets debossed with to the left of the score and to the right of the score on one side of the tablet and on the other side. They are available as follows:NDC 0179-0074-70Box of 30 Unit Dose TabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Mylan Pharmaceuticals Inc.Morgantown, WV 26505REVISED DECEMBER 2009ESTRT:R4ppt Repackaged by: KAISER FOUNDATION HOSPITALS Livermore, CA 94551Estradiol Tablets, USP are available containing 0.5 mg or 1 mg of estradiol, USP.The 0.5 mg tablets are white to off-white round, scored tablets debossed with to the left of the score and to the right of the score on one side of the tablet and on the other side. They are available as follows:NDC 0179-0073-70Box of 30 Unit Dose TabletsThe 1 mg tablets are pink round, scored tablets debossed with to the left of the score and to the right of the score on one side of the tablet and on the other side. They are available as follows:NDC 0179-0074-70Box of 30 Unit Dose TabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Mylan Pharmaceuticals Inc.Morgantown, WV 26505REVISED DECEMBER 2009ESTRT:R4ppt Repackaged by: KAISER FOUNDATION HOSPITALS Livermore, CA 94551Estradiol Tablets, USP are available containing 0.5 mg or 1 mg of estradiol, USP.The 0.5 mg tablets are white to off-white round, scored tablets debossed with to the left of the score and to the right of the score on one side of the tablet and on the other side. They are available as follows:NDC 0179-0073-70Box of 30 Unit Dose TabletsThe 1 mg tablets are pink round, scored tablets debossed with to the left of the score and to the right of the score on one side of the tablet and on the other side. They are available as follows:NDC 0179-0074-70Box of 30 Unit Dose TabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Mylan Pharmaceuticals Inc.Morgantown, WV 26505REVISED DECEMBER 2009ESTRT:R4ppt Repackaged by: KAISER FOUNDATION HOSPITALS Livermore, CA 94551Estradiol Tablets, USP are available containing 0.5 mg or 1 mg of estradiol, USP.The 0.5 mg tablets are white to off-white round, scored tablets debossed with to the left of the score and to the right of the score on one side of the tablet and on the other side. They are available as follows:NDC 0179-0073-70Box of 30 Unit Dose TabletsThe 1 mg tablets are pink round, scored tablets debossed with to the left of the score and to the right of the score on one side of the tablet and on the other side. They are available as follows:NDC 0179-0074-70Box of 30 Unit Dose TabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Mylan Pharmaceuticals Inc.Morgantown, WV 26505REVISED DECEMBER 2009ESTRT:R4ppt Repackaged by: KAISER FOUNDATION HOSPITALS Livermore, CA 94551Estradiol Tablets, USP are available containing 0.5 mg or 1 mg of estradiol, USP.The 0.5 mg tablets are white to off-white round, scored tablets debossed with to the left of the score and to the right of the score on one side of the tablet and on the other side. They are available as follows:NDC 0179-0073-70Box of 30 Unit Dose TabletsThe 1 mg tablets are pink round, scored tablets debossed with to the left of the score and to the right of the score on one side of the tablet and on the other side. They are available as follows:NDC 0179-0074-70Box of 30 Unit Dose TabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Mylan Pharmaceuticals Inc.Morgantown, WV 26505REVISED DECEMBER 2009ESTRT:R4ppt Repackaged by: KAISER FOUNDATION HOSPITALS Livermore, CA 94551Estradiol Tablets, USP are available containing 0.5 mg or 1 mg of estradiol, USP.The 0.5 mg tablets are white to off-white round, scored tablets debossed with to the left of the score and to the right of the score on one side of the tablet and on the other side. They are available as follows:NDC 0179-0073-70Box of 30 Unit Dose TabletsThe 1 mg tablets are pink round, scored tablets debossed with to the left of the score and to the right of the score on one side of the tablet and on the other side. They are available as follows:NDC 0179-0074-70Box of 30 Unit Dose TabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Mylan Pharmaceuticals Inc.Morgantown, WV 26505REVISED DECEMBER 2009ESTRT:R4ppt Repackaged by: KAISER FOUNDATION HOSPITALS Livermore, CA 94551Estradiol Tablets, USP are available containing 0.5 mg or 1 mg of estradiol, USP.The 0.5 mg tablets are white to off-white round, scored tablets debossed with to the left of the score and to the right of the score on one side of the tablet and on the other side. They are available as follows:NDC 0179-0073-70Box of 30 Unit Dose TabletsThe 1 mg tablets are pink round, scored tablets debossed with to the left of the score and to the right of the score on one side of the tablet and on the other side. They are available as follows:NDC 0179-0074-70Box of 30 Unit Dose TabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Mylan Pharmaceuticals Inc.Morgantown, WV 26505REVISED DECEMBER 2009ESTRT:R4ppt Repackaged by: KAISER FOUNDATION HOSPITALS Livermore, CA 94551Estradiol Tablets, USP are available containing 0.5 mg or 1 mg of estradiol, USP.The 0.5 mg tablets are white to off-white round, scored tablets debossed with to the left of the score and to the right of the score on one side of the tablet and on the other side. They are available as follows:NDC 0179-0073-70Box of 30 Unit Dose TabletsThe 1 mg tablets are pink round, scored tablets debossed with to the left of the score and to the right of the score on one side of the tablet and on the other side. They are available as follows:NDC 0179-0074-70Box of 30 Unit Dose TabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Mylan Pharmaceuticals Inc.Morgantown, WV 26505REVISED DECEMBER 2009ESTRT:R4ppt Repackaged by: KAISER FOUNDATION HOSPITALS Livermore, CA 94551Estradiol Tablets, USP are available containing 0.5 mg or 1 mg of estradiol, USP.The 0.5 mg tablets are white to off-white round, scored tablets debossed with to the left of the score and to the right of the score on one side of the tablet and on the other side. They are available as follows:NDC 0179-0073-70Box of 30 Unit Dose TabletsThe 1 mg tablets are pink round, scored tablets debossed with to the left of the score and to the right of the score on one side of the tablet and on the other side. They are available as follows:NDC 0179-0074-70Box of 30 Unit Dose TabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Mylan Pharmaceuticals Inc.Morgantown, WV 26505REVISED DECEMBER 2009ESTRT:R4ppt Repackaged by: KAISER FOUNDATION HOSPITALS Livermore, CA 94551Estradiol Tablets, USP are available containing 0.5 mg or 1 mg of estradiol, USP.The 0.5 mg tablets are white to off-white round, scored tablets debossed with to the left of the score and to the right of the score on one side of the tablet and on the other side. They are available as follows:NDC 0179-0073-70Box of 30 Unit Dose TabletsThe 1 mg tablets are pink round, scored tablets debossed with to the left of the score and to the right of the score on one side of the tablet and on the other side. They are available as follows:NDC 0179-0074-70Box of 30 Unit Dose TabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Mylan Pharmaceuticals Inc.Morgantown, WV 26505REVISED DECEMBER 2009ESTRT:R4ppt Repackaged by: KAISER FOUNDATION HOSPITALS Livermore, CA 94551Estradiol Tablets, USP are available containing 0.5 mg or 1 mg of estradiol, USP.The 0.5 mg tablets are white to off-white round, scored tablets debossed with to the left of the score and to the right of the score on one side of the tablet and on the other side. They are available as follows:NDC 0179-0073-70Box of 30 Unit Dose TabletsThe 1 mg tablets are pink round, scored tablets debossed with to the left of the score and to the right of the score on one side of the tablet and on the other side. They are available as follows:NDC 0179-0074-70Box of 30 Unit Dose TabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Mylan Pharmaceuticals Inc.Morgantown, WV 26505REVISED DECEMBER 2009ESTRT:R4ppt Repackaged by: KAISER FOUNDATION HOSPITALS Livermore, CA 94551


×

Clinical Information

Chemical Structure

No Image found
Clinical Pharmacology

Non-Clinical Toxicology
The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.

In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.

Butalbital, Aspirin, and Caffeine Capsules, USP may enhance the effects of:

Butalbital, Aspirin, and Caffeine Capsules, USP may diminish the effects of:

Uricosuric agents such as probenecid and sulfinpyrazone, reducing their effectiveness in the treatment of gout. Aspirin competes with these agents for protein binding sites.

Suicidal Ideation - Monitor for suicidality, clinical worsening, and unusual changes in behavior. ()

Severe Liver Injury – Should be discontinued and not restarted in patients with jaundice or laboratory evidence of liver injury. ()

Serious Cardiovascular Events - Sudden death, stroke and myocardial infarction have been reported in association with atomoxetine treatment. Patients should have a careful history and physical exam to assess for presence of cardiovascular disease. Atomoxetine hydrochloride generally should not be used in children or adolescents with known serious structural cardiac abnormalities, cardiomyopathy, serious heart rhythm abnormalities, or other serious cardiac problems that may place them at increased vulnerability to its noradrenergic effects. Consideration should be given to not using atomoxetine hydrochloride in adults with clinically significant cardiac abnormalities. ()

Emergent Cardiovascular Symptoms - Patients should undergo prompt cardiac evaluation. ()

Effects on Blood Pressure and Heart Rate - Can increase blood pressure and heart rate; orthostasis, syncope and Raynaud’s phenomenon may occur. Use with caution in patients with hypertension, tachycardia, or cardiovascular or cerebrovascular disease. ().

Emergent Psychotic or Manic Symptoms - Consider discontinuing treatment if such new symptoms occur. ()

Bipolar Disorder - Screen patients to avoid possible induction of a mixed/manic episode. ()

Aggressive behavior or hostility should be monitored. ()

Possible allergic reactions, including anaphylactic reactions,  angioneurotic edema, urticaria, and rash. ()

Effects on Urine Outflow - Urinary hesitancy and retention may occur. ()

Priapism - Prompt medical attention is required in the event of suspected priapism. (, )

Growth - Height and weight should be monitored in pediatric patients. ()

Concomitant Use of Potent CYP2D6 Inhibitors or Use in patients known to be CYP2D6 PMs- Dose adjustment of atomoxetine hydrochloride may be necessary. ()

×

Reference

This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

×

Review

Rate this treatment and share your opinion


Learn about User Reviews

Helpful tips to write a good review:

  1. Only share your first hand experience as a consumer or a care giver.
  2. Describe your experience in the Comments area including the benefits, side effects and how it has worked for you. Do not provide personal information like email addresses or telephone numbers.
  3. Fill in the optional information to help other users benefit from your review.

Reason for Taking This Treatment

(required)

Click the stars to rate this treatment

Effectiveness (required)

This medication has worked for me.




Ease of Use (required)

This medication has been easy for me to use.




Satisfaction (required)

Overall, I have been satisfied with my experience.




Write a brief description of your experience with this treatment:

2000 characters remaining

Optional Information

Help others benefit from your review by filling in the information below.
I am a:
Gender:
×

Professional

Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72
×

Tips

Tips

×

Interactions

Interactions

A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).